N-heterocyclic aromatics (NHA) are a subgroup pf polycyclic aromatic hydrocarbons (PAH) which are environmentally important pollutants which are found in complex mixtures. The overall goal of this research program has been to evaluate the role of NHA in the carcinogenicity of PAH mixtures in the environment. We have focused on the relative carcinogenicity of two model NHA, dibenzo[c,g]carbazole (DBC) and dibenz[a,j]acridine (DBA). We have discovered that there are distinct differences in the metabolism of these compounds, which affects profoundly the carcinogenicity. We are now beginning to understand how small structural and chemical differences, between DBC and DBA, contribute to large differences in metabolism, organotropism and carcinogenicity. Building on these results and our experience, we hypothesize that the structural and metabolic differences between these two compounds will have an impact at multiple stages in the carcinogenic process including DNA adduction and repair, mutational spectra, and global gene expression. We also hypothesize that these structural and metabolic differences will cause DBA and DBC to interact differently with a model PAH, benzo[a]pyrene (BAP), when there is co-exposure in binary mixtures. These will be addressed by the following specific aims involving the characterization of the metabolic activation, DNA damage and biological effects of the lesions produced by DBC and DBA in mouse skin, and liver and in human liver cells: 1) Elucidate the mechanism of activation of DBC and DBA in vitro and in vivo. 2) Characterize the types of DNA lesions induced by DBC and DBA in human liver cells and in mouse liver and skin including bulky adducts, apurinic sites and oxidative damage. 3) Determine the effects of binary mixtures of DBC and BaP, or DBA and BaP on biological endpoints including metabolism, DNA adducts and ras mutational spectra. This approach will provide valuable information on the metabolic activation and biological consequences of mixtures of NHA and lead to a better understanding of the mechanism(s) of carcinogenesis. An important effort, in the next research period, will be to relate the differences we are discovering in the structure of DBC and DBA with their biological effects, up to and including, how each behave as components of PAH mixtures. Using this approach, we will begin to understand the interaction between components of mixtures.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
5R01ES004203-17
Application #
6929845
Study Section
Chemical Pathology Study Section (CPA)
Program Officer
Balshaw, David M
Project Start
1997-09-01
Project End
2007-07-31
Budget Start
2005-08-01
Budget End
2007-07-31
Support Year
17
Fiscal Year
2005
Total Cost
$287,616
Indirect Cost
Name
University of Cincinnati
Department
Public Health & Prev Medicine
Type
Schools of Medicine
DUNS #
041064767
City
Cincinnati
State
OH
Country
United States
Zip Code
45221
Talaska, Glenn; Ginsburg, David; LaDow, Kathy et al. (2006) Impact of Cyp1a2 or Ahr gene knockout in mice: implications for biomonitoring studies. Toxicol Lett 162:246-9
Xue, Weiling; Warshawsky, David (2005) Metabolic activation of polycyclic and heterocyclic aromatic hydrocarbons and DNA damage: a review. Toxicol Appl Pharmacol 206:73-93
O'Brien, T; Schneider, J; Warshawsky, D et al. (2002) In vitro toxicity of 7H-dibenzo[c,g]carbazole in human liver cell lines. Toxicol In Vitro 16:235-43
Xue, Weiling; Siner, Angela; Rance, Mark et al. (2002) A metabolic activation mechanism of 7H-dibenzo[c,g]carbazole via o-quinone. Part 2: covalent adducts of 7H-dibenzo[c,g]carbazole-3,4-dione with nucleic acid bases and nucleosides. Chem Res Toxicol 15:915-21
Gray, D L; Warshawsky, D; Xue, W et al. (2001) The effects of a binary mixture of benzo(a)pyrene and 7H-dibenzo(c,g)carbazole on lung tumors and K-ras oncogene mutations in strain A/J mice. Exp Lung Res 27:245-53
Mitchell, K R; Warshawsky, D (2001) Comparison of Ha-ras mutational spectra of N-methyldibenzo[c,g]carbazole and 7H-dibenzo[c,g]carbazole-induced mouse skin tumors. Mol Carcinog 32:55-60
Xue, W; Schneider, J; Mitchell, K et al. (2001) trans-3,4-dihydroxy-anti-1,2-epoxy-1,2,3,4-tetrahydrodi- benz[a,j]acridine involvement in dibenz[a,j]acridine DNA adduct formation in mouse skin consistent with Ha-ras mutation patterns in tumors. Chem Res Toxicol 14:871-8
Dowty, H V; Xue, W; LaDow, K et al. (2000) One-electron oxidation is not a major route of metabolic activation and DNA binding for the carcinogen 7H-dibenzo[c,g]carbazole in vitro and in mouse liver and lung. Carcinogenesis 21:991-8
O'Brien, T; Babcock, G; Cornelius, J et al. (2000) A comparison of apoptosis and necrosis induced by hepatotoxins in HepG2 cells. Toxicol Appl Pharmacol 164:280-90
Mitchell, K R; Warshawsky, D (1999) Frequent Ha-ras mutations in murine skin and liver tumors induced by 7H-dibenzo[c,g]carbazole. Mol Carcinog 25:107-12

Showing the most recent 10 out of 27 publications